Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Rolland

Showing results (101-110 of 224) with videos related to

Pageof 23
Sort By:
Therapie|June 6, 2020
Prolonged-release buprenorphine formulations: Perspectives for clinical practiceMathieu Chappuy, Benoit Trojak, Philippe Nubukpo, et al.
Alcohol (Fayetteville, N.Y.)|November 10, 2022
Longitudinal determinants of insomnia among patients with alcohol use disorderIngeborg Bolstad, Helge Toft, Lars Lien, et al.
Therapie|July 7, 2019
A capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in FranceMarine Auffret, Benjamin Rolland, Hélène Béhal, et al.
Therapie|June 5, 2020
[Prolonged-release buprenorphine formulations: Perspectives for clinical practice]Mathieu Chappuy, Benoit Trojak, Philippe Nubukpo, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|August 8, 2020
[Analgesic opioids misuse in the elderly: A review]Manon Cublier, Pascal Menecier, Armin von Gunten, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|April 9, 2021
Misuse of opioid analgesics in elderly patients: a reviewManon Cublier, Pascal Menecier, Armin von Gunten, et al.
Biological Psychiatry|November 7, 2012
Per-symptomatic brain activations in alcohol-induced hallucinosisVincent Laprevote, Benjamin Rolland, Olivier Cottencin, et al.
Psychiatry Research|June 23, 2024
Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims databaseBenjamin Rolland, Nabil Hallouche, Olivier Lada, et al.
Therapie|May 21, 2016
[Investigation of the medical and social situation of patients managed by opiate replacement regimens for over 10 years by their GP]Nassir Messaadi, Jonathan Favre, Benjamin Rolland, et al.
Current Pharmaceutical Design|June 20, 2015
GABAB Agonists for the Treatment of Alcohol Use DisorderAntonio Mirijello, Fabio Caputo, Gabriele Vassallo, et al.
Pageof 23

Showing results (101-110 of 224) with videos related to

Sort By:
Pageof 23
Therapie|June 6, 2020
Prolonged-release buprenorphine formulations: Perspectives for clinical practiceMathieu Chappuy, Benoit Trojak, Philippe Nubukpo, et al.
Alcohol (Fayetteville, N.Y.)|November 10, 2022
Longitudinal determinants of insomnia among patients with alcohol use disorderIngeborg Bolstad, Helge Toft, Lars Lien, et al.
Therapie|July 7, 2019
A capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in FranceMarine Auffret, Benjamin Rolland, Hélène Béhal, et al.
Therapie|June 5, 2020
[Prolonged-release buprenorphine formulations: Perspectives for clinical practice]Mathieu Chappuy, Benoit Trojak, Philippe Nubukpo, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|August 8, 2020
[Analgesic opioids misuse in the elderly: A review]Manon Cublier, Pascal Menecier, Armin von Gunten, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|April 9, 2021
Misuse of opioid analgesics in elderly patients: a reviewManon Cublier, Pascal Menecier, Armin von Gunten, et al.
Biological Psychiatry|November 7, 2012
Per-symptomatic brain activations in alcohol-induced hallucinosisVincent Laprevote, Benjamin Rolland, Olivier Cottencin, et al.
Psychiatry Research|June 23, 2024
Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims databaseBenjamin Rolland, Nabil Hallouche, Olivier Lada, et al.
Therapie|May 21, 2016
[Investigation of the medical and social situation of patients managed by opiate replacement regimens for over 10 years by their GP]Nassir Messaadi, Jonathan Favre, Benjamin Rolland, et al.
Current Pharmaceutical Design|June 20, 2015
GABAB Agonists for the Treatment of Alcohol Use DisorderAntonio Mirijello, Fabio Caputo, Gabriele Vassallo, et al.
Pageof 23